Evidence-based global cardiovascular disease control priority interventions

Mark D. Huffman*, P. P. Mohanan, Dorairaj Prabhakaran

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)247-250
Number of pages4
JournalIndian Journal of Medical Research
Volume148
Issue number3
DOIs
StatePublished - Sep 1 2018

Funding

Financial support & sponsorship: The first author (MDH) received support from the National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA for work related to this report (award R00HL107749). He also received support from the World Heart Federation to serve as senior programme advisor for the World Heart Federation’s Emerging Leaders program, which is supported by unrestricted educational grants from Boehringer Ingelheim and Novartis with previous support by AstraZeneca and BUPA. He has also received support from the American Heart Association, Verily, and AstraZeneca for work unrelated to this manuscript. The last author (DP) received unrestricted education grants from Merck Sharp & Dohma (MSD), Eli Lilly, GlaxoSmithKline, Torrent and Sun Pharmaceuticals for primary care physician training programmes.

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Cite this